|
|
|
Overview |
|
|
Definition |
|
A stroke occurs when there is a disruption of the cerebral blood flow to the
brain, resulting in temporary or permanent neurologic deficits. There are two
broad categories of stroke. Ischemic stroke (cerebral infarction) accounts for
80% of all strokes and results from embolic obstruction or from thrombosis.
Hemorrhagic stroke, the other 20% of strokes, results from bleeding either into
the subarachnoid space or the parenchyma of the brain. In the United States,
approximately 550,000 individuals suffer a stroke annually. Half of these people
are left disabled and endure years of rehabilitation. |

|
|
Etiology |
|
Ischemic:
Thrombotic:
- Ulcerated atherosclerotic plaque site develops a blood clot in a area
of turbulent blood flow and occludes an artery
- Protein C or S deficiency
- Sickle cell anemia
- Polycythemia vera
- Drug abuse
Embolic:
- Mitral stenosis produces thrombi, causing large cerebral
emboli
- Valvular heart disease
- Bacterial endocarditis
- Atrial fibrillation
- Myocardial infarction (MI)
- Artery-to-artery embolus
- Lacunar—diabetes, hypertension;
atherosclerosis of small arteries
- Cerebral atherothromboembolism of unknown
source—hypercoaglability factors
Hemorrhagic:
- Intracerebral—bleeding directly into brain
matter, usually at bifurcations of major arteries at base of brain
- Subarachnoid—bleeding outside brain
parenchyma into cerebrospinal fluids (CSF) generally either from arteriovenous
malformations or cerebral aneurysms; three-fourths occur at the circle of Willis
- Small arteries, damaged by age and hypertension,
rupture
|

|
|
Risk Factors |
|
- TIAs, history of stroke
- Aging
- Men > women
- Hypertension
- Heart disease
- Traumatic injury
- Substance abuse (cocaine, alcohol)
- Total serum cholesterol—for older
patients
- Diabetes
- Increased blood viscosity
- African or Japanese Americans
- Use of oral contraceptives
- Smoking
|

|
|
Signs and Symptoms |
|
Vary depending on location
- Ischemic stroke—sudden or insidious onset of
focal deficits; paresthesias; hemiparesis; hemianopia; hemisensory deficits;
swallowing difficulties; aphasia; pallor; pain
- Hemorrhagic stroke—altered mental status may
deteriorate rapidly to coma; focal neurologic deficits; vomiting; headache
(excruciating if subarachnoid); dysphagia; hemiparesis
- Transient ischemic attacks (TIAs)—resolve
within 24 hours (usually 5 to 20 minutes); 50% of patients will have a stroke
within five years
|

|
|
Differential
Diagnosis |
|
- Brain tumor
- Hematoma—subdural or epidural
- Brain abscess
- Migraine
- Hypoglycemia
- Meningitis
- Encephalitis
- Glaucoma
- Dementia
- Labyrinthitis
|

|
|
Diagnosis |
|
|
Physical Examination |
|
Pallor and altered mental status may be apparent. Patient may complain of
pain and/or numbness. |

|
|
Laboratory Tests |
|
Complete blood count:
- Platelet count—identifies thrombocytosis,
thrombocytopenia
- Coagulation study
- Blood viscosity
- Cardiac isoenzymes
Erythrocyte sedimentation rate:
- Urinalysis
- Drug screening
|

|
|
Pathology/Pathophysiology |
|
- Cerebral blood flow (CBF) below 15 to 18 ml/100 g of
brain/min—areas where brain loses electrical activity
evidence neurologic deficit
- CBF below 10 ml/100 g of brain/min—membrane
integrity and function failure occurs; anoxia leads to cerebral infarction
- Free radical formation, glutamate release, and increased extracellular
potassium and intracellular calcium potentiate neuronal death
- Total depletion of adenosine triphosphate (ATP) within five minutes,
causing lactate and glucose levels to rise
excessively
|

|
|
Imaging |
|
- Computerized tomography (CT)—distinguishes
ischemic (takes 6+ hours) from hemorrhagic (reliable diagnosis 95%) stroke;
differential diagnoses
- Magnetic resonance imaging—less accurate
distinguishing ischemic from hemorrhagic stroke than CT; identifies acute
posterior stroke, vascular malformations, tumor
- Angiogram—accurately measures degree of
stenosis; identifies location of hemorrhages, aneurysms
|

|
|
Other Diagnostic
Procedures |
|
- Check temperature, breathing, airway passage clearance
- Neurologic examination
- Funduscopic evaluation
- Motor/sensory evaluation
- Cerebral evaluation—assessment of reflexes
and gait
- Electrocardiogram (EKG)—reveals atrial
fibrillation, MI
- Echocardiogram—identifies thrombus,
tumor
- Lumbar puncture—diagnoses hemorrhagic stroke
when blood is found in the
CSF
|

|
|
Treatment Options |
|
|
Treatment Strategy |
|
Effective management now focuses on emergent treatment targeted for the
specific location and type of injury that has occurred with the goal of
preventing neurologic deficits from becoming irreversible. The therapeutic
window is estimated at two to six hours. Intervention and support,
psychotherapy, and drug treatments may be employed. General strategies include
the following.
- Control glucose level
- Administer oxygen
- Maintain airway—possible intubation
- Maintain cerebral perfusion
- Elevate head—promotes venous
drainage
- Hyperventilation—decreases intracranial
pressure
- Control overhydration—prevents cerebral
edema
- Control dehydration—prevents further
ischemia; isotonic saline—can cause cardiac or renal
disease
- Lumbar puncture—for subarachnoid
hemorrhage
|

|
|
Drug Therapies |
|
- Treat only severe hypertension (e.g., carefully titrated nitroprusside
or angiotensin-converting enzyme)—prevents irreversible
damage to the penumbra, recurrent bleeding
- Thrombolytic therapy—aids vasoconstriction
and platelet aggregation; prevents MI, deep venous thrombosis, pulmonary
embolism; recombinant tissue plasminogen activator (rt-PA) 1.1 mg/kg to 100 mg
maximum, 10% bolus, remainder infused over 1 hour; side
effect—intracerebellar bleeding; contraindicated in
hemorrhagic stroke
- Diuretics—reduce cerebral edema; possible
rebound swelling
- Calcium-channel blockers—prevent vasospasm
with subarachnoid hemorrhage; nimodipine 60 mg every 6 hours
- Anticoagulants (e.g., heparin 3,000 to 5,000 units intravenously)
reduces stenosis, cardioembolic stroke recurrence, stroke from nonvalvular
atrial fibrillation; contraindicated in hemorrhagic stroke
- Antiplatelets—commonly used for strokes of
undetermined origin; aspirin 300 mg/day
|

|
|
Surgical Procedures |
|
- Especially for brain stem compression, ventricular
obstruction
- Prophylactically for subarachnoid hemorrhage (prevents infarction,
further ischemia)
- Cartoid endarterectomy (removes stenotic
plaques)
|

|
|
Complementary and Alternative
Therapies |
|
CAM for strokes includes prevention and treatment of risk factors
(hypertension, diabetes, and cardiovascular disease) and preventing recurrences.
Regular exercise and/or physical therapy is very important. Diet and nutrition
play an important role. Homeopathy can sometimes provide dramatic relief. Gingko
is an important part of any treatment. Other herbs may be useful.
|

|
|
Nutrition |
|
- Diet: high fiber, low saturated fat, low sodium, high potassium, high
magnesium foods
- Alcohol increases risk of hemorrhagic stroke, probably due to its
effect on platelet aggregation.
- Garlic and onion help regulate lipids and atherosclerosis.
- Folate: deficiencies associated with hyperhomocystinemia and
cardiovascular disease (400 to 800 IU/day)
- Essential fatty acids: regulate platelet aggregation and arachidonic
acid metabolites. Reduce animal fats and increase fish. A mix of omega-6
(evening primrose) and omega-3 (flaxseed) may be optimal (2 tablespoons oil/day
or 1,000 to 1,500 IU bid).
- Vitamin E: 400 to 1,600 IU/day, may protect against cerebral
thrombosis, antioxidant
- Coenzyme Q10: 10 to 50 mg/day, increases oxygenation of heart and
other tissues
- Vitamin C: 1,000 mg tid: antioxidant to prevent progressive tissue
damage
- Bromelain: 250 mg tid between meals, decreases inflammation at the
vascular level, which may be a precipitating factor in stroke and
recurrences
|

|
|
Herbs |
|
Herbs may be used as dried extracts (pills, capsules, or tablets), teas, or
tinctures (alcohol extraction, unless otherwise noted). Dose for teas is 1
heaping tsp. herb/cup water steeped for 10 minutes (roots need 20
minutes).
- Gingko biloba may be used specifically for depression and/or
dementia post-stroke due to decreased blood flow (60 to 80 mg tid), also used
for arterial occlusive disease. Use carefully with hemorrhagic
stroke.
- Hawthorn (Crataegus species) used in mild cardiac
insufficiency, with historic use as a heart and vascular tonic and to strengthen
connective tissue
- Mistletoe (Viscum album) to treat and prevent
atherosclerosis
|

|
|
Homeopathy |
|
An experienced homeopath would consider an individual's constitutional type
to prescribe a more specific remedy and potency. Some of the most common acute
remedies are listed below. Acute dose is three to five pellets of 12X to 30C
every one to four hours until symptoms resolve.
- Acontitum napellus for numbness and/or paralysis after a
cerebral accident that is associated with a great anxiety
- Belladonna for stroke that leaves person very sensitive to any
motion, with vertigo and trembling
- Kali bromatum for stroke resulting in restlessness, wringing of
the hands or other repeated gestures, insomnia, and night terrors
- Nux vomica for cerebral accident with paresis, expressive
aphasia, convulsions, and great
irritability
|

|
|
Acupuncture |
|
Anecdotal, but worth considering for rehabilitation. Scalp acupuncture, in
particular, may be helpful during rehabilitation
process. |

|
|
Patient Monitoring |
|
Patients should be hospitalized with stroke, then monitored carefully at
residential rehabilitation facility or home for potential recurrence. Physical
therapy and/or speech therapy may help patients relearn and improve motor skills
and speech. |

|
|
Other
Considerations |
|
|
Prevention |
|
- Aspirin—reduces recurrence; 300
mg/day
- Prevention of known risks (e.g., anticoagulants for atrial
fibrillation, controlling diabetes) significantly prevents
stroke
|

|
|
Complications/Sequelae |
|
- Seizure
- Depression—up to 50% of patients
- Deep venous thrombosis
- Urinary tract infection
- Pneumonia
- Cytotoxic edema
- Vasospasm
- Pulmonary emboli
- Dementia—about 20% of
patients
|

|
|
Prognosis |
|
- Overall mortality—30%; hemorrhage
mortality—35% to 50% at 30 days
- 90% of deaths occur in the first week
Rehabilitation is often long, involving physical and occupational
therapies:
- 80% ambulatory
- 60% achieve self-care
- 25% permanent moderate to severe
deficits
|

|
|
Pregnancy |
|
The use of oral contraceptives and pregnancy both increase the risk of
stroke. |

|
|
References |
|
Bartram T. Encyclopedia of Herbal Medicine. Dorset, England: Grace
Publishers;1995:407-408.
Blumenthal M, ed. The Complete German Commission E Monographs. Boston,
Mass: Integrative Medicine Communications; 1998:134, 136-138, 142-144,
176-177.
Bennett JC, ed. Cecil Textbook of Medicine. 20th ed. Philadelphia, Pa:
W.B. Saunders; 1996.
Dambro MR. Griffith's 5-Minute Clinical Consult. 1999 ed. Baltimore,
Md: Lippincott Williams & Wilkins, Inc.; 1999.
Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles
of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998.
Gruenwald J, Brendler T, Jaenicke C, eds. PDR for Herbal Medicines.
Montvale, NJ: Medical Economics Company; 1998:779-81, 1219-22.
Kane E. Stroke. American Association of Naturopathic Physicians.
Accessed at www.healthy.net/library/articles/naturopathic/art.strk.htm on July
29, 1999.
Kaplan HW, ed. Comprehensive Textbook of Psychiatry. 6th ed.
Baltimore, Md: Williams & Wilkins; 1995.
Morrison R. Desktop Guide to Keynotes and Confirmatory Symptoms.
Albany, Calif: Hahnemann Clinic Publishing; 1993:3-6, 58-62, 198-199,
272-276.
Rakel RE, ed. Conn's Current Therapy. 50th ed. Philadelphia, Pa: W.B.
Saunders; 1998.
Rosen P, ed. Emergency Medicine: Concepts and Clinical Management. 4th
ed. St. Louis, Mo: Mosby-Year Book; 1998.
Swain RA, St Clair L. The role of folic acid in deficiency states and
prevention of disease. J Fam Pract.
1997;44(2):138-144. |

|
Copyright © 2000 Integrative Medicine
Communications This publication contains
information relating to general principles
of medical care that should not in any event be construed as specific
instructions for individual patients. The publisher does not accept any
responsibility for the accuracy of the information or the consequences arising
from the application, use, or misuse of any of the information contained herein,
including any injury and/or damage to any person or property as a matter of
product liability, negligence, or otherwise. No warranty, expressed or implied,
is made in regard to the contents of this material. No claims or endorsements
are made for any drugs or compounds currently marketed or in investigative use.
The reader is advised to check product information (including package inserts)
for changes and new information regarding dosage, precautions, warnings,
interactions, and contraindications before administering any drug, herb, or
supplement discussed herein. | |